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Abstract  
Novel optically active 5,5-dioxophenothiazine bis(urea) and bis(thiourea) derivatives were 
synthesized and their enantiomeric recognition abilities toward the enantiomers of 
tetrabutylammonium salts of α-hydroxy and N-protected α-amino acids were examined in 
acetonitrile using fluorescence spectroscopy. 
 
 
 
1. Introduction 
Enantiomeric recognition as a special case of molecular recognition is a widespread and vital 
phenomenon in Nature. A great number of biologically important molecules are chiral, and many 
biological processes are based on enantioselective reactions. Since one of the enantiomers of a 
biologically active chiral compound may have different toxicological and pharmacological 
properties than the other, the determination of the enantiomeric composition of chiral organic 
compounds has great significance in drug discovery, food industry and pesticide chemistry. 
Carboxyl group is a very common functional group in amino acids, enzymes, metabolic 
intermediates and several physiologically active molecules. Therefore, the synthesis and studies of 
sensor and selector molecules, which are able to distinguish between the enantiomers of chiral 
2 
carboxylic acids, are of great interest. The enantiomers of chiral carboxylic acids can be 
differentiated in their neutral forms,
1,2
 and in most cases as their deprotonated forms by 
enantioselective anion receptors.
2–24
 The enantiomeric recognition of chiral carboxylic acids as 
carboxylates is advantageous, because carboxylic acids exist in their dissociated forms under 
physiological conditions.
13,21
 
The most frequently used chiral motifs in anion receptors are amino acid, BINOL, steroid and 
monosaccharide units,
2–14,19–22
 but among others 1-arylethyl
24–29
 moieties have also been applied as 
sources of chirality. These sensor molecules often contain urea and thiourea units as receptor parts, 
which have good hydrogen bond donating ability therefore high affinity toward anions.
2
 Some 
chiral anion sensors possessing two urea or thiourea moieties have a fluorescent signalling unit, 
which provide a sensitive tool for the examination of their anion recognition ability by the use of 
fluorescence spectroscopy.
2,24,29–38
  
Neutral anion sensors, which bind anions via hydrogen bonds for example with their amide, 
urea or thiourea moieties,
39
 can also contain a heterocyclic unit having a slightly acidic NH group 
such as pyrrole,
40
 indole or carbazole
41
 and in a few cases, acridone
24,42–44
 or 5,5-
dioxophenothiazine.
45–47
 In our research group, achiral bis(amide),
45
 bis(urea),
46
 bis(thiourea)
46
 and 
chiral bis(thiourea)
47
 type 5,5-dioxophenothiazine-based sensor molecules (1–5, Fig. 1) were 
synthesized, and their anion recognition properties were studied by UV–vis spectroscopy. 
 
 
 
Figure 1. Reported 5,5-dioxophenothiazine-based anion sensors. 
 
 
In this paper, we report the synthesis of novel 5,5-dioxophenothiazine bis(urea) and 
bis(thiourea) derivatives containing (S)-1-arylethyl units [(S,S)-6–(S,S)-9, Scheme 1] as well as the 
UV–vis and fluorescence studies on their complexation properties and enantiomeric recognition 
abilities toward the enantiomers of different optically active tetrabutylammonium carboxylates in 
acetonitrile. 
3 
2. Results and discussion 
2.1. Synthesis 
The synthesis of new 5,5-dioxophenothiazine bis(urea) and bis(thiourea) derivatives containing 
(S)-1-arylethyl units [(S,S)-6–(S,S)-9] was carried out as outlined in Scheme 1. Diamine 1045 was 
reacted with the appropriate commercially available optically active isocyanate and isothiocyanate 
in pyridine to give bis(urea) and bis(thiourea) derivatives (S,S)-6–(S,S)-9. 
 
 
Scheme 1. Synthesis of receptors (S,S)-6–(S,S)-9. 
 
 
 
2.2. Enantiomeric recognition studies 
The complexation properties and enantiomeric recognition abilities of receptors (S,S)-8 and 
(S,S)-9 toward the enantiomers of tetrabutylammonium salts of mandelic acid (Man), tert-
butoxycarbonyl-protected phenylglycine (Boc-Phg), tert-butoxycarbonyl-protected phenylalanine 
(Boc-Phe) and tert-butoxycarbonyl-protected alanine (Boc-Ala) were studied in acetonitrile by UV–
vis and fluorescence spectroscopies (Fig. 2). 
 
 
 
Figure 2. Optically active tetrabutylammonium carboxylates used in the enantiomeric recognition studies. 
4 
Since basic anions often cause the deprotonation of neutral anion sensors, we recorded the UV–
vis spectra of the deprotonated forms of receptors (S,S)-8 and (S,S)-9 using 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) as a strong base (Fig. 3). 
 
 
Figure 3. Absorption spectra of (S,S)-8, (S,S)-9 and their deprotonated forms (20 µM) (A and B) in MeCN. 
 
 
Upon addition of carboxylate anions to receptors (S,S)-8 and (S,S)-9, the absorption spectra 
showed changes due to complexation, and no spectral changes characteristic to deprotonation could 
be observed (Fig. 4.). 
 
 
 
Figure 4. Series of absorption spectra upon titration of (S,S)-8 (20 µM) with (R)-Boc-Phg (0, 0.2, 0.4, 0.7, 1, 2 equiv) 
(A) and (S,S)-9 (20 µM) with (R)-Boc-Phg (0, 0.2, 0.5, 1, 2 equiv) (B) in MeCN. 
 
 
5 
However, the complex formations with the chiral carboxylates were almost quantitative at the 
applied concentration of the sensor molecules (20 µM), and manifested in slight spectral changes in 
the case of thiourea receptor (S,S)-9 (Fig. 4). Because of these, it was more advantageous to follow 
the complexation processes by fluorescence spectroscopy using significantly lower concentrations 
of the sensor molecules (5, 3 or 2 µM), which also provided larger spectral changes in the case of 
thiourea derivative (S,S)-9 (see later). 
The fluorescence emission spectra of the neutral and deprotonated forms of receptors (S,S)-8 
and (S,S)-9 were taken (Fig. 5), and the fluorescence quantum yields of these species were also 
determined (Table 1). Both neutral sensor molecules have low fluorescence quantum yields, and 
comparing them, a considerably lower value can be observed in the case of thiourea derivative 
(S,S)-9. The latter can be attributed to the quenching effect of the sulphur atoms in the molecule, 
probably due to a photoinduced electron transfer (PET) process.
24,48–50
 In both cases, the 
deprotonation significantly decreases the fluorescence quantum yields. 
 
 
Figure 5. Fluorescence emission spectra of (S,S)-8, (S,S)-9 and their deprotonated forms (20 µM) (A and B) in MeCN, 
λex = 310 nm. 
 
 
Table 1 
Fluorescence quantum yields of (S,S)-8, (S,S)-9 and their deprotonated forms in MeCN, λex = 325 nm. 
 
Φf 
 
neutral form deprotonated form
(S,S)-8 0.032 0.0037 
(S,S)-9 0.0053 0.0013 
6 
The fluorescence emission spectra of receptors (S,S)-8 and (S,S)-9 showed 17–32% increases 
and 33–45% decreases, respectively, at their maxima upon addition of the carboxylates (Fig. 6 and 
7), which could be fitted satisfactorily (considering the residual analysis
51
 also) by assuming 1:1 
complex formation, and the stability constants were calculated (Table 2). 
 
 
 
Figure 6. Series of fluorescence emission spectra upon titration of (S,S)-8 (5 µM) with (S)-Man (0, 0.2, 0.4, 0.8, 1.2, 
1.6, 2.4, 4, 10 equiv) in MeCN, λex = 320 nm.  
 
 
 
 
 
Figure 7. Series of fluorescence emission spectra upon titration of (S,S)-9 (5 µM) with (S)-Boc-Phg (0, 0.2, 0.4, 1, 2, 4, 
8, 20 equiv) in MeCN, λex = 340 nm (A). Titration curves with (R)-Boc-Phg and (S)-Boc-Phg (0–8 equiv) at 381 nm 
(B). 
 
 
7 
Table 2 
Stability constants for complexes of (S,S)-8 and (S,S)-9 with the enantiomers of optically active tetrabutylammonium 
carboxylates and the degrees of enantiomeric recognition in MeCN 
  
  (S,S)-8 (S,S)-9 
  log K   log K log K   log K
(R)-Man 5.50 
0.09 
5.16 
–0.11 
(S)-Man 5.41 5.27 
(R)-Boc-Phg 5.79 
0.03 
5.71 
0.24 
(S)-Boc-Phg 5.76 5.47 
(R)-Boc-Phe 5.87  
–0.07 
6.09 
0.12 
(S)-Boc-Phe 5.94 5.97 
(R)-Boc-Ala 5.94  
0.12 
6.01 
0.10 
(S)-Boc-Ala 5.82 5.91 
 
 
In most cases, receptors (S,S)-8 and (S,S)-9 showed slight or no enantiomeric recognition 
abilities toward the enantiomers of chiral carboxylates (Table 2). However, in the case of thiourea 
receptor (S,S)-9 and the enantiomers of Boc-Phg, moderate selectivity could be observed, which 
was the highest among the others. These results suggest that the enantiomeric differentation is based 
on very subtle effects.
19
 One of these effects is the type of the receptor units (urea or thiourea) in the 
anion sensors, which significantly influenced the recognition ability toward the enantiomers of Boc-
Phg. The structure of the guest molecules also affected the enantioselectivity: the presence of a 
hydroxyl group (in Man) instead of the protected amino group (in Boc-Phg) and the presence of a 
benzyl (aralkyl) group (in Boc-Phe) or a methyl (alkyl) group (in Boc-Ala) instead of the phenyl 
group (in Boc-Phg) decreased the recognition ability of receptor (S,S)-9. This preference of receptor 
(S,S)-9 is similar to that of the reported bis(thiourea) derivative 5 containing glucopyranosyl groups, 
in which case the highest enantioselectivity was also observed toward (R)-Boc-Phg over its (S)-
isomer (∆ log K = 0.22) among the same chiral carboxylates.47 Another trend can be observed: the 
stability constants of complexes with the enantiomers of Man are lower than those with the 
enantiomers of amino acid derivatives (Boc-Phg, Boc-Phe, Boc-Ala) in the cases of 5,5-
dioxophenothiazine-based anion sensors 5, (S,S)-8 and (S,S)-9. 
The complexation properties of receptors (S,S)-6 and (S,S)-7 toward the chiral carboxylates 
were also examined. Sensor molecules (S,S)-6 and (S,S)-7 showed similar, but considerably smaller 
absorption and fluorescence spectral changes compared to those of receptors (S,S)-8 and (S,S)-9. 
These slight changes did not allow the accurate determination of the stability constants of 
8 
complexes, therefore, the enantiomeric recognition abilities of receptors (S,S)-6 and (S,S)-7 could 
not be evaluated. 
 
3. Conclusion 
We synthesized four 5,5-dioxophenothiazine derivatives as potential enantioselective anion 
sensors, and their absorption and fluorescence behaviour in the presence of the enantiomers of 
tetrabutylammonium salts of α-hydroxy and N-protected α-amino acids were studied. Receptors 
(S,S)-6 and (S,S)-7 containing phenyl groups at their stereogenic centres gave considerably small 
absorption and fluorescence spectral changes upon addition of the carboxylates, which did not allow 
the accurate determination of the stability constants of these complexes. However, derivatives (S,S)-
8 and (S,S)-9 containing 1-naphthyl groups at their stereogenic centres showed larger spectral 
changes in the presence of the chiral carboxylates, and the enantiomeric recognition abilities were 
evaluated based on the fluorescence spectral changes. The highest enantioselectivity, which is a 
moderate one, could be observed in the case of receptor (S,S)-9 and the enantiomers of Boc-Phg.  
 
4. Experimental 
4.1. General 
Starting materials were purchased from Sigma–Aldrich Corporation unless otherwise noted. 
(S)-1-(1-Naphthyl)ethyl isothiocyanate was obtained from Alfa Aesar. Silica gel 60 F254 (Merck) 
plates were used for TLC. Silica gel 60 F254 (Merck) plates (1 mm) were used for PLC. Silica gel 60 
(70–230 mesh, Merck) was used for column chromatography. Ratios of solvents for the eluents are 
given in volumes (mL/mL). Solvents were dried and purified according to well established 
methods.
52
 Evaporations were carried out under reduced pressure. 
Melting points were taken on a Boetius micro-melting point apparatus and are uncorrected. 
Optical rotations were taken on a Perkin–Elmer 241 polarimeter, which was calibrated by 
measuring the optical rotations of both enantiomers of menthol. IR spectra were recorded on a 
Bruker Alpha-T FT-IR spectrometer. 
1
H (500 MHz) NMR spectra were obtained on a Bruker DRX-
500 Avance spectrometer. 
1
H (300 MHz) and 
13
C (75.5 MHz) NMR spectra were obtained on a 
Bruker 300 Avance spectrometer. The signals of NH protons in the 
1
H NMR spectra were helped to 
identify by shaking the NMR samples with D2O. Mass spectra were recorded on an Agilent-6120 
Single Quadrupole LC/MS instrument using ESI method. Elemental analyses were performed in the 
9 
Microanalytical Laboratory of the Department of Organic Chemistry, Institute for Chemistry, L. 
Eötvös University, Budapest, Hungary.  
UV–vis spectra were taken on a Unicam UV4-100 spectrophotometer. Quartz cuvettes with 
path length of 1 cm were used. Fluorescence spectra were recorded on a Perkin–Elmer LS 50B 
luminescent spectrometer. Emission spectra were corrected by the spectrometer software. Quartz 
cuvettes with path length of 1 cm were used. Fluorescence quantum yields were determined relative 
to quinine sulfate (Φf = 0.53 in 0.1 M H2SO4).
38
 Stability constants of the complexes were 
determined by global nonlinear regression analysis using SPECFIT/32
TM
 software. 
The enantiomers of mandelic acid and Boc-protected amino acids were purchased from Sigma–
Aldrich Corporation. The tetrabutylammonium salts of the anions were prepared by adding 1 equiv 
of carboxylic acid to 1 equiv of Bu4NOH dissolved in MeOH. After evaporating MeOH, the salts 
were dried under reduced pressure over P2O5. During the fluorescence titrations, the concentrations 
of the solutions of receptors (S,S)-6–(S,S)-9 were 2, 3 and 5 µM, and the concentrations of the 
titrant solutions of chiral carboxylates were 0.2, 0.5, 1 and 10 mM. 
 
4.2. General procedure for the synthesis of receptors (S,S)-6–(S,S)-9 
To a stirred solution of diamine 10
45
 (200 mg, 0.535 mmol) in pyridine (3 mL) was added the 
solution of the appropriate (S)-1-arylethyl isocyanate (1.12 mmol, R = phenyl: 165 mg, R = 1-
naphthyl: 222 mg) or (S)-1-arylethyl isothiocyanate (1.61 mmol, R = phenyl: 262 mg, R = 1-
naphthyl: 342 mg) in pyridine (2 mL) under Ar at rt. The mixture was stirred at rt for 1 h (X = O) or 
2 days (X = S) (see Scheme 1). After the reaction was completed, the reaction mixture was poured 
into a water–ice mixture, and acidified to pH 2 using concentrated hydrochloric acid. The 
precipitate was filtered off, washed with water, and the crude product was purified as described 
below for each compound. 
 
4.2.1. 1,1’-(3,7-Di-tert-butyl-5,5-dioxo-5,10-dihydro-5λ6-phenothiazine-1,9-diyl)bis{3-[(1S)-1-
phenylethyl]urea} [(S,S)-6]. The crude product was triturated with ethanol to give receptor (S,S)-6 
(203 mg, 57%) as off-white crystals. Mp: 216–217°C; Rf: 0.46 (silica gel TLC, MeOH–CH2Cl2 
1:20); [ ] 
   = +65.2, [ ]   
   = +69.5, [ ]   
   = +81.3, [ ]   
   = +154 (c 1.00, DMF); IR (KBr) νmax 
3372, 3085, 3063, 3030, 2965, 2907, 2871, 1665, 1609, 1547, 1495, 1453, 1365, 1240, 1137, 901, 
875, 760, 701, 600, 547 cm
–1
; 
1
H NMR (500 MHz, DMSO-d6) δ 1.30 (s, 18H), 1.39 (d, J = 6 Hz, 
6H), 4.82–4.97 (m, 2H), 7.18–7.47 (m, 10H + 2H, NH), 7.51 (s, 2H), 7.98 (s, 2H), 9.08 (br s, 2H, 
10 
NH), 9.20 (br s, 1H, NH); 
13
C NMR (75.5 MHz, DMSO-d6) δ 23.55, 30.86, 34.36, 49.08, 111.68, 
121.34, 123.88, 125.73, 126.61, 127.64, 128.27, 128.40, 144.25, 145.09, 154.80; MS calcd for 
C38H45N5O4S: 667.3, found (M+H)
+
: 668.3; Anal. calcd for C38H45N5O4S: C 68.34, H 6.79, N 
10.49, S 4.80, found: C 68.11, H 6.91, N 10.24, S 4.53. 
 
4.2.2. 1,1’-(3,7-Di-tert-butyl-5,5-dioxo-5,10-dihydro-5λ6-phenothiazine-1,9-diyl)bis{3-[(1S)-1-
phenylethyl]thiourea} [(S,S)-7]. The crude product was purified by preparative layer 
chromatography using 1:20 MeOH–CH2Cl2 as an eluent to give receptor (S,S)-7 (220 mg, 59%) as 
yellow crystals. Mp: 155–156°C; Rf: 0.85 (silica gel TLC, MeOH–CH2Cl2 1:20); [ ] 
   = 
+34.3, [ ]   
   = +35.7, [ ]   
   = +42.2, [ ]   
   = +105 (c 0.67, CH2Cl2); IR (KBr) νmax 3346, 3085, 
3062, 3030, 2965, 2870, 1606, 1494, 1454, 1366, 1286, 1139, 1095, 1024, 901, 884, 756, 700, 552 
cm
–1
; 
1
H NMR (500 MHz, CDCl3) δ 1.31 (s, 18H), 1.55 (d, J = 7 Hz, 6H), 5.48–5.62 (m, 2H), 6.04–
6.32 (br s, 2H, NH), 7.10–7.39 (m, 12H), 8.02 (s, 2H), 8.76 (br s, 1H, NH), 10.07 (br s, 2H, NH); 
13
C NMR (75.5 MHz, CDCl3) δ 22.53, 31.29, 35.13, 54.72, 119.26, 123.07, 123.49, 126.49, 127.60, 
128.81, 129.90, 132.10, 142.76, 146.16, 180.25; MS calcd for C38H45N5O2S3: 699.3, found (M+H)
+
: 
700.3; Anal. calcd for C38H45N5O2S3: C 65.20, H 6.48, N 10.00, S 13.74, found: C 64.95, H 6.19, N 
9.76, S 13.49. 
 
4.2.3. 1,1’-(3,7-Di-tert-butyl-5,5-dioxo-5,10-dihydro-5λ6-phenothiazine-1,9-diyl)bis{3-[(1S)-1-
(naphthalen-1-yl)ethyl]urea} [(S,S)-8]. The crude product was triturated with ethanol to give 
receptor (S,S)-8 (318 mg, 77%) as off-white crystals. Mp: 184–187°C; Rf: 0.68 (silica gel TLC, 
iPrOH–hexane 1:5); [ ] 
   = +38.9, [ ]   
   = +40.6, [ ]   
   = +46.6, [ ]   
   = +96.5 (c 1.04, DMF); 
IR (KBr) νmax 3369, 3063, 3051, 3012, 2964, 2905, 2870, 1667, 1609, 1544, 1494, 1450, 1396, 
1365, 1286, 1239, 1138, 1056, 900, 875, 799, 778, 728, 598, 549 cm
–1
; 
1
H NMR (500 MHz, 
DMSO-d6) δ 1.28 (s, 18H), 1.54 (d, J = 7 Hz, 6H), 5.66–5.75 (m, 2H), 7.14 (d, J = 8 Hz, 2H, NH), 
7.45–7.56 (m, 6H), 7.58 (d, J = 2 Hz, 2H), 7.66 (d, J = 7 Hz, 2H), 7.69 (d, J = 2 Hz, 2H), 7.81 (d, J 
= 8 Hz, 2H), 7.92 (d, J = 8 Hz, 2H), 8.15 (d, J = 8 Hz, 2H), 8.60 (s, 2H, NH), 9.72 (s, 1H, NH); 
13
C 
NMR (75.5 MHz, DMSO-d6) δ 22.33, 30.85, 34.33, 45.25, 112.93, 121.38, 122.16, 123.10, 125.02, 
125.46, 125.60, 126.19, 127.31, 127.52, 128.67, 129.77, 130.19, 133.44, 140.34, 144.21, 155.33; 
MS calcd for C46H49N5O4S: 767.4, found (M+H)
+
: 768.4; Anal. calcd for C46H49N5O4S·H2O: C 
70.29, H 6.54, N 8.91, S 4.08, found: C 70.03, H 6.67, N 8.69, S 4.29. 
 
11 
4.2.4. 1,1’-(3,7-Di-tert-butyl-5,5-dioxo-5,10-dihydro-5λ6-phenothiazine-1,9-diyl)bis{3-[(1S)-1-
(naphthalen-1-yl)ethyl]thiourea} [(S,S)-9]. The crude product was purified by column 
chromatography on silica gel using 1:15 iPrOH–hexane as an eluent to give receptor (S,S)-9 (214 
mg, 50%) as yellow crystals. Mp: 167–170°C; Rf: 0.42 (silica gel TLC, iPrOH–hexane 1:7); [ ] 
   = 
+116, [ ]   
   = +121, [ ]   
   = +142, [ ]   
   = +297 (c 0.71, CH2Cl2); IR (KBr) νmax 3346, 3098, 
3050, 3014, 2963, 2906, 2869, 1605, 1494, 1467, 1366, 1286, 1240, 1138, 900, 884, 798, 777, 734, 
648, 556 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 1.04 (s, 18H), 1.77 (d, J = 6 Hz, 6H), 6.04–6.52 (m, 
2H + 2H, NH), 7.15–7.35 (m, 4H), 7.43–7.61 (m, 6H), 7.72 (d, J = 8 Hz, 2H), 7.85 (d, J = 8 Hz, 
2H), 7.90 (s, 2H), 8.20 (d, J = 8 Hz, 2H), 8.64 (br s, 1H, NH), 9.88 (br s, 2H, NH); 
13
C NMR (75.5 
MHz, CDCl3) δ 21.49, 30.99, 34.83, 51.33, 119.12, 122.98, 123.31, 123.41, 125.54, 125.64, 126.10, 
127.02, 128.52, 129.17, 129.76, 131.00, 132.08, 134.16, 138.07, 146.24, 180.20; MS calcd for 
C46H49N5O2S3: 799.3, found (M+H)
+
: 800.3; Anal. calcd for C46H49N5O2S3: C 69.05, H 6.17, N 
8.75, S 12.02, found: C 68.94, H 5.92, N 8.49, S 11.85. 
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